InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,718.57
(
0.28%
)
US TECH 100
19,361.20
(
0.20%
)
Dow Jones
42,124.65
(
0.00%
)
Brent Oil
74.87
(
1.54%
)
Bitcoin
63,494.16
(
0.26%
)
Post# of 43369
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonDonDonDon

Send PM Follow Ignore
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

DonDonDonDon

Re: ArchieK post# 35999

Wednesday, 04/06/2022 10:51:33 AM

Wednesday, April 06, 2022 10:51:33 AM

Post# of 43369

So the EUA for sotrovimab is revoked. Because it doesn't deal with variants. Anyone know of something that is variant agnostic laying around somewhere??


So much time, effort, and money was put into developing treatments that are now useless. Variant agnostic therapies are clearly the answer for a virus that evolves too quickly for science to keep up. There is still no authorized treatment that is effective for newly hospitalized patients. Lenzilumab is the answer for today, lenzilumab is the answer for tomorrow.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up